Efficacy of vitamin D supplementation in patients diagnosed with depression: a dose–response meta-analysis of randomized controlled trials
Open Access
- 17 March 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1772451
Abstract
Background: Depression affects 5% of the global population, posing significant health and economic challenges. Objectives: This study evaluates the efficacy of vitamin D supplementation in reducing depressive symptoms and explores its dose–response relationship. Methods: We used PubMed, EMBASE, and Cochrane Library to identify randomized controlled trials using the keyword combination of vitamin D and depression from inception to June 2024. The primary outcome was the change in depressive symptoms. A dose–response meta-analysis using restricted cubic splines was conducted to explore potential sources of heterogeneity and examine the dose–response relationship. Results: The outcomes were reported in 15 studies encompassing data from 962 participants. Vitamin D supplementation demonstrated a significant improvement in depressive symptoms compared to the placebo group (SMD: −0.98; 95% CI − 1.28 to −0.68; p < 0.001). Statistical heterogeneity was high ( I 2 = 79%; p < 0.001). Secondary outcomes revealed significant reductions in serum PTH (MD: −4.19; 95% CI − 8.18 to −0.2 pg./mL) and TNFα levels (MD: −0.3; 95% CI − 0.44 to −0.16 pg./mL) in the intervention groups, while other outcomes, such as BMI, weight, and IL-6, showed no significant changes. Dose–response analysis further highlighted that higher daily doses of vitamin D, particularly up to 5,000 IU/day, were associated with the greatest reduction in depressive symptoms. Conclusion: Our findings from this systematic review and meta-analysis indicated that vitamin D supplementation may be an effective adjunctive therapy for improving depressive symptoms. The observed reductions in serum PTH and TNFα levels suggest anti-inflammatory mechanisms underlying its antidepressant effects. Higher daily doses, particularly around 5,000 IU, were associated with greater symptom improvement within the studied populations.Keywords
This publication has 65 references indexed in Scilit:
- Global Burden Disease Estimates for Major Depressive Disorders (MDD): A review of diagnostic instruments used in studies of prevalenceCommunity Mental Health Journal, 2024
- Association of Body Weight With Response to Vitamin D Supplementation and MetabolismJAMA Network Open, 2023
- Effect of vitamin D supplementation on depression in older Australian adultsInternational Journal of Geriatric Psychiatry, 2022
- A randomized, double-blind, placebo-controlled, 12-week trial of vitamin D augmentation in major depressive disorder associated with vitamin D deficiencyJournal of Affective Disorders, 2022
- Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiencyBrain and Behavior, 2020
- The effect of vitamin D supplement on negative emotions: A systematic review and meta‐analysisDepression and Anxiety, 2020
- Effect of vitamin D deficiency on depressive symptoms in child and adolescent psychiatric patients: results of a randomized controlled trialEuropean Journal of Nutrition, 2020
- Effect of vitamin D supplementation on depression in elderly patients: A randomized clinical trialClinical Nutrition, 2019
- Overweight, Obesity, and DepressionArchives of General Psychiatry, 2010
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002